Skip to main content
. 2022 Jul 25;27(15):4766. doi: 10.3390/molecules27154766

Figure 2.

Figure 2

Stability of ibrutinib (A,B), dihydrodiol ibrutinib (C,D) and the active moiety (sum of ibrutinib and dihydrodiol ibrutinib concentrations) (E,F) in whole blood (A,C,E) and in plasma (B,D,F) at 25 °C over 6 h in 3 independent samples. The dashed line (- - -) displays the limit for judging analyte stability as acceptable (0.85).